ivorenoside A

dimeric antioxidant and cytotoxic compound from Terminalia ivorensis A. Chev; structure in first source

Also Known As:

beta-D-glucopyranosyl-18,19-seco-2alpha,3beta,19,19,24-pentahydroxyolean-12-en-28-oate

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Barboni, Luciano: 1 article (12/2010)
2.	Bramucci, Massimo: 1 article (12/2010)
3.	Lupidi, Giulio: 1 article (12/2010)
4.	Ponou, Beaudelaire Kemvoufo: 1 article (12/2010)
5.	Quassinti, Luana: 1 article (12/2010)
6.	Ricciutelli, Massimo: 1 article (12/2010)
7.	Tapondjou, Léon Azefack: 1 article (12/2010)
8.	Teponno, Rémy Bertrand: 1 article (12/2010)

1.	Neoplasms (Cancer) 12/01/2010 - "Ivorenoside B and C exhibited scavenging activity against DPPH and ABTS(+) radicals with IC(50) values comparable with that of the standard drug Trolox and ivorenoside A showed antiproliferative activity against MDA-MB-231 and HCT116 human cancer cell lines with IC(50) values of 3.96 and 3.43 μM, respectively."

1.	ivorenoside B
2.	6- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)
3.	2,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)